InvestorsObserver
×
News Home

Do Traders Think Mirati Therapeutics Inc (MRTX) Can Turn Around Wednesday?

Wednesday, January 11, 2023 02:58 PM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think Mirati Therapeutics Inc (MRTX) Can Turn Around Wednesday?

Mirati Therapeutics Inc (MRTX) stock is down 15.79% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bearish
Mirati Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on MRTX!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With MRTX Stock Today?

Mirati Therapeutics Inc (MRTX) stock is lower by -0.44% while the S&P 500 has gained 0.93% as of 2:57 PM on Wednesday, Jan 11. MRTX has fallen -$0.18 from the previous closing price of $40.45 on volume of 1,214,855 shares. Over the past year the S&P 500 is down -15.30% while MRTX has fallen -67.67%. MRTX lost -$13.38 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Mirati Therapeutics Inc click here.

More About Mirati Therapeutics Inc

Mirati Therapeutics Inc is a clinical-stage oncology company developing novel therapeutics to address the genetic and immunological promoters of cancer. It operates in a single geographical segment being the United States. Click Here to get the full Stock Report for Mirati Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App